François-Clément Bidard Circulating Tumor Biomarkers Laboratory, SiRIC, Translational Research Department Institut Curie, PSL Research University Biography Publications Institution JoVE Articles François-Clément Bidard has not added a biography. If you are François-Clément Bidard and would like to personalize this page please email our Author Liaison for assistance. Publications Prognostic Impact of Residual HPV CtDNA Detection After Chemoradiotherapy for Anal Squamous Cell Carcinoma Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2018 | Pubmed ID: 30054279 Clinical Potential of Circulating Tumour DNA in Patients Receiving Anticancer Immunotherapy Nature Reviews. Clinical Oncology. Oct, 2018 | Pubmed ID: 30050094 Cdk4/6 Inhibitors and Overall Survival: Power of First-line Trials in Metastatic Breast Cancer NPJ Breast Cancer. 2018 | Pubmed ID: 29951582 Outlier Response to Anti-PD1 in Uveal Melanoma Reveals Germline MBD4 Mutations in Hypermutated Tumors Nature Communications. May, 2018 | Pubmed ID: 29760383 Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis Journal of the National Cancer Institute. Jun, 2018 | Pubmed ID: 29659933 Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR Clinical Chemistry. Feb, 2018 | Pubmed ID: 29122835 RECIST Response and Variation of Circulating Tumour Cells in Phase 1 Trials: A Prospective Multicentric Study European Journal of Cancer (Oxford, England : 1990). 09, 2017 | Pubmed ID: 28743036 HPV Circulating Tumor DNA to Monitor the Efficacy of Anti-PD-1 Therapy in Metastatic Squamous Cell Carcinoma of the Anal Canal: A Case Report International Journal of Cancer. 10, 2017 | Pubmed ID: 28670746 Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2017 | Pubmed ID: 28351929 Circulating Tumor Cells: Clinical Validity and Utility International Journal of Clinical Oncology. Jun, 2017 | Pubmed ID: 28238187 Patient-Specific Circulating Tumor DNA Detection During Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Clinical Chemistry. Mar, 2017 | Pubmed ID: 28073896 FISH-in-CHIPS: A Microfluidic Platform for Molecular Typing of Cancer Cells Methods in Molecular Biology (Clifton, N.J.). 2017 | Pubmed ID: 28044298 ERBB2 Mutations Associated with Solid Variant of High-grade Invasive Lobular Breast Carcinomas Oncotarget. Nov, 2016 | Pubmed ID: 27602491 Clinical Applications of Circulating Tumor DNA and Circulating Tumor Cells in Pancreatic Cancer Molecular Oncology. Mar, 2016 | Pubmed ID: 26856794 Circulating Tumor Cells in Breast Cancer Molecular Oncology. Mar, 2016 | Pubmed ID: 26809472 Circulating Tumor DNA for Triple-negative Breast Cancer Diagnosis and Treatment Decisions Expert Review of Molecular Diagnostics. 2016 | Pubmed ID: 26568208 High Purity Microfluidic Sorting and Analysis of Circulating Tumor Cells: Towards Routine Mutation Detection Lab on a Chip. May, 2015 | Pubmed ID: 25815443 Time to Metastatic Relapse and Breast Cancer Cells Dissemination in Bone Marrow at Metastatic Relapse Clinical & Experimental Metastasis. 2008 | Pubmed ID: 18989740 Tek damlacık dijital polimeraz zincir tepkimesi mutasyonlar Hotspot bölgelerde kapsamlı ve eşzamanlı algılanması için Charles Decraene1,2, Amanda Bortolini Silveira1, Marc Michel1, François-Clément Bidard1,3,4, Jean-Yves Pierga1,3,5, Marc-Henri Stern1,6, Charlotte Proudhon1 1Circulating Tumor Biomarkers Laboratory, SiRIC, Translational Research Department, Institut Curie, PSL Research University, 2CNRS UMR144, Institut Curie, PSL Research University, 3Department of Medical Oncology, Institut Curie, PSL Research University, 4University Versailles Saint-Quentin-en-Yvelines, 5University Paris Descartes, 6Inserm U830, Institut Curie, PSL Research University JoVE 58051 Genetics
Tek damlacık dijital polimeraz zincir tepkimesi mutasyonlar Hotspot bölgelerde kapsamlı ve eşzamanlı algılanması için Charles Decraene1,2, Amanda Bortolini Silveira1, Marc Michel1, François-Clément Bidard1,3,4, Jean-Yves Pierga1,3,5, Marc-Henri Stern1,6, Charlotte Proudhon1 1Circulating Tumor Biomarkers Laboratory, SiRIC, Translational Research Department, Institut Curie, PSL Research University, 2CNRS UMR144, Institut Curie, PSL Research University, 3Department of Medical Oncology, Institut Curie, PSL Research University, 4University Versailles Saint-Quentin-en-Yvelines, 5University Paris Descartes, 6Inserm U830, Institut Curie, PSL Research University JoVE 58051 Genetics
